Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417984
Max Phase: Preclinical
Molecular Formula: C44H85N7O15S5
Molecular Weight: 1112.53
Molecule Type: Unknown
Associated Items:
ID: ALA2417984
Max Phase: Preclinical
Molecular Formula: C44H85N7O15S5
Molecular Weight: 1112.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC[C@@H]1C[C@@H](C(=O)NC([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)SCCOCCSSCCOCCSC[C@H]2O[C@@H](O[C@@H]3[C@@H](O)[C@H](O[C@H]4O[C@H](CN)[C@@H](O)C[C@H]4N)[C@@H](N)C[C@H]3N)[C@H](O)[C@@H](N)[C@@H]2O)N(C)C1
Standard InChI: InChI=1S/C44H85N7O15S5/c1-5-6-22-15-26(51(3)19-22)41(59)50-31(40-35(56)34(55)36(57)44(66-40)67-4)21(2)69-12-8-61-10-14-71-70-13-9-60-7-11-68-20-29-32(53)30(49)33(54)43(63-29)65-39-24(47)16-23(46)38(37(39)58)64-42-25(48)17-27(52)28(18-45)62-42/h21-40,42-44,52-58H,5-20,45-49H2,1-4H3,(H,50,59)/t21-,22-,23+,24-,25-,26+,27+,28-,29-,30+,31?,32-,33-,34+,35-,36-,37+,38-,39+,40-,42-,43+,44-/m1/s1
Standard InChI Key: ZWWDTHPQQGYQFN-GXXNRNNYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1112.53 | Molecular Weight (Monoisotopic): 1111.4707 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Berkov-Zrihen Y, Green KD, Labby KJ, Feldman M, Garneau-Tsodikova S, Fridman M.. (2013) Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance., 56 (13): [PMID:23786357] [10.1021/jm400707f] |
Source(1):